ATOH1
Transcription factor ATOH1
Also known as: ATOH1_HUMAN, bHLHa14, HATH1, MATH-1, Math1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q92858
- Gene
- ATOH1
- Ensembl
- ENSG00000172238
- Chromosome
- 4
- Canonical length
- 354 aa
- Protein class
- Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in several processes, including neuron differentiation; positive regulation of neuron differentiation; and positive regulation of transcription by RNA polymerase II. Predicted to act upstream of or within several processes, including generation of neurons; neuroblast migration; and positive regulation of inner ear auditory receptor cell differentiation. Predicted to be located in chromatin. Predicted to be active in nucleus. Implicated in autosomal dominant nonsyndromic deafness 89. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
354 residues, UniProt reviewed canonical sequence.
>Q92858|ATOH1
1 MSRLLHAEEW AEVKELGDHH RQPQPHHLPQ PPPPPQPPAT LQAREHPVYP PELSLLDSTD
61 PRAWLAPTLQ GICTARAAQY LLHSPELGAS EAAAPRDEVD GRGELVRRSS GGASSSKSPG
121 PVKVREQLCK LKGGVVVDEL GCSRQRAPSS KQVNGVQKQR RLAANARERR RMHGLNHAFD
181 QLRNVIPSFN NDKKLSKYET LQMAQIYINA LSELLQTPSG GEQPPPPPAS CKSDHHHLRT
241 AASYEGGAGN ATAAGAQQAS GGSQRPTPPG SCRTRFSAPA SAGGYSVQLD ALHFSTFEDS
301 ALTAMMAQKN LSPSLPGSIL QPVQEENSKT SPRSHRSDGE FSPHSHYSDS DEASLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATOH1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.68
- Highest tissue expression
- 19 nTPM
Expression across tissuesHPA
Tissue
- small intestine: 19 nTPM
- rectum: 17 nTPM
- colon: 17 nTPM
- duodenum: 10 nTPM
- appendix: 1.5 nTPM
- smooth muscle: 0.4 nTPM
Single-cell type
- goblet cells: 288 nCPM
- paneth cells: 16 nCPM
- mesothelial cells: 5.4 nCPM
- enteric transient amplifying cells: 3.8 nCPM
- gastric progenitor cells: 3.8 nCPM
- enteric stem cells: 3.5 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- medulla oblongata: 0.2 nTPM
- hypothalamus: 0.1 nTPM
- pons: 0.1 nTPM
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ATOH1.
Disease | AllUniProt
Conditions ATOH1 is implicated in, by any mechanism.
- Deafness, autosomal dominant, 89 (DFNA89) MIM:620284
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 74 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Dominant progressive sensorineural hearing loss
- Hearing loss, autosomal dominant 89
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.05
- gnomAD pLI
- 0.02
- gnomAD missense Z
- -0.13
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- axon development
- axon guidance
- central nervous system development
- central nervous system neuron differentiation
- cerebral cortex development
- epithelial cell apoptotic process
- inner ear morphogenesis
- negative regulation of epithelial cell apoptotic process
- negative regulation of gliogenesis
- neuroblast migration
- neuron fate commitment
- neuron migration
- Notch signaling pathway
- positive regulation of inner ear auditory receptor cell differentiation
- positive regulation of neuron differentiation
- positive regulation of transcription by RNA polymerase II
- sensory organ development
- transcription by RNA polymerase II
- auditory receptor cell fate determination
- auditory receptor cell fate specification
Molecular functions
- chromatin DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- E-box binding
- protein dimerization activity
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Myc-type, basic helix-loop-helix (bHLH) domain
- Helix-loop-helix DNA-binding domain superfamily
- Basic helix-loop-helix transcription factors
- Helix-loop-helix DNA-binding domain
- Transcription factor ATOH1, basic helix-loop-helix domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATOH1 as an antibody target. Whether an autoantibody or antibody against ATOH1 could matter depends on whether native ATOH1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATOH1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ATOH1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...